Mukka Proteins Limited
All news and filings related to Mukka Proteins Limited.
View all news & filings- Medium impact
Mukka Proteins Limited Re-appoints Key Directors and Management at 16th AGM
Mukka Proteins Limited re-appointed three Non-Executive Independent Directors and three key management personnel at its 16th AGM on September 10, 2026. The re-appointments for directors and management are for five-year terms, effective January 15, 2027, and January 20, 2027, respectively.
Read the summary - Low impact
Mukka Proteins Limited Holds 16th AGM on Sep 10, 2026, Discusses Financials and Re-appointments
Mukka Proteins Limited held its 16th AGM on September 10, 2026. The meeting reviewed financial statements for FY26 and discussed director re-appointments and borrowing limits. Key managerial personnel, including the MD & CEO, CFO, and COO, were proposed for re-appointment. Approval was also sought for related party transactions.
Read the summary - Medium impact
Mukka Proteins Allots 2 Crore Warrants Worth ₹47 Crore to Non-Promoters
Mukka Proteins Limited approved the allotment of 2 crore convertible warrants to 15 non-promoter investors. The issue price is ₹23.50 per warrant, totaling ₹47 crore. Warrants are convertible into equity shares within 18 months upon payment of the balance issue price.
Read the summary - Medium impact
Mukka Proteins Receives EU Inputs Attestation for Organic Fertilizer
Mukka Proteins received an EU Inputs Attestation from ECOCERT S.A.S. for its "Eco Sphere Organic Fertilizer". The attestation, valid until March 31, 2028, confirms suitability for organic farming and aims to boost marketability in the EU and other organic markets.
Read the summary - Medium impact
Mukka Proteins to Invest ₹13.19 Crore in Shipwaves Online
Mukka Proteins will invest up to ₹13.19 crore in Shipwaves Online Limited (SOL) by acquiring equity shares. SOL's FY26 turnover was ₹65.01 crore and PAT was ₹1.68 crore. The deal aims for logistics synergies and is expected to conclude by March 31, 2027. Post-acquisition, Mukka's stake will be 16.77%.
Read the summary - High impact
Mukka Proteins expands into waste-to-value, scaling Bengaluru's wet waste conversion.
Mukka Proteins is scaling Bengaluru's wet waste conversion into insect protein, oil, compost, and humic acid. The company aims to process up to 1,000 TPD of wet waste, with intake expected to reach 400 TPD by March 2027 and 1,000 TPD by December 2027. This initiative generates four revenue streams and aligns with ESG goals.
Read the summary - Medium impact
Mukka Proteins Receives In-Principle Approval for Preferential Warrant Issue
Mukka Proteins received in-principle approval from NSE and BSE for issuing 2 crore convertible warrants to non-promoters on a preferential basis. The issue price is ₹23.50 per warrant. Approvals are subject to various regulatory compliances and conditions, including enhanced internal controls.
Read the summary - Low impact
Mukka Proteins corrects investment consideration to ₹66.25 Lakh for Swachha Eco Solutions
Mukka Proteins Limited corrected its investment disclosure for Swachha Eco Solutions Private Limited (SESPL). The total consideration was revised to ₹66.25 Lakh from ₹64.93 Lakh due to a calculation error. The number of shares (26,500) and price per share (₹250) remain unchanged. The acquisition, aimed at expanding the Waste Management segment, is expected to be completed by 31st December 2026.
Read the summary - Low impact
Mukka Proteins to hold 16th AGM on Sep 10, 2026, via Video Conference
Mukka Proteins Limited will conduct its 16th Annual General Meeting on September 10, 2026, at 3:00 PM IST via Video Conference. E-voting will be open from September 7 to September 9, 2026. The cut-off date for voting eligibility is September 3, 2026.
Read the summary - Low impact
Mukka Proteins to hold 16th AGM on Sep 10, 2026, via VC/OVAM
Mukka Proteins Limited will hold its 16th Annual General Meeting on September 10, 2026, at 3:00 PM IST via Video Conferencing. The Annual Report for FY 2025-26 and AGM notice are being sent electronically to registered shareholders. A weblink is provided for shareholders with unregistered email addresses.
Read the summary - Medium impact
Mukka Proteins Announces 16th AGM on Sep 10, 2026; Releases FY26 Annual Report
Mukka Proteins will hold its 16th AGM on September 10, 2026. The company reported FY26 consolidated revenue of ₹1,449.5 crore (up 44.0%) and PAT of ₹57.1 crore (up 18.7%). They aim for ₹3,000 crore revenue by FY30, supported by diversification and international expansion.
Read the summary - Low impact
Mukka Proteins Announces 16th AGM on September 10, 2026
Mukka Proteins Limited will hold its 16th Annual General Meeting on September 10, 2026, at 3:00 PM IST. The meeting will be conducted via Video Conferencing with e-voting facilities available. Members are advised to update their contact details with DPs for receiving AGM notices and annual reports.
Read the summary - Low impact
Mukka Proteins Announces 16th AGM on Sep 10, 2026
Mukka Proteins Limited will hold its 16th AGM on September 10, 2026, at 3:00 p.m. IST via video conference. The company will share the AGM notice and annual report for FY25-26 with members shortly.
Read the summary - Low impact
Mukka Proteins Announces Unaudited Financial Results for Q1 FY27
Mukka Proteins Limited announced its unaudited financial results for the quarter ended June 30, 2026. The results were approved by the Board on August 12, 2026, and published on August 14, 2026. Full details are available on the company and stock exchange websites.
Read the summary - Medium impact
Mukka Proteins to Invest ₹64.9 Lakhs for 25.98% Stake in Swachha Eco Solutions
Mukka Proteins will invest up to ₹64.92 Lakhs for a 25.98% stake in Swachha Eco Solutions Private Limited. This strategic move aims to expand Mukka's Waste Management segment. The acquisition is expected to be completed by December 31, 2026.
Read the summary - Low impact
Mukka Proteins Withdraws ₹75 Crore NCD Issuance Approved in May 2026
Mukka Proteins Limited has withdrawn its plan to issue Non-Convertible Debentures (NCDs) worth ₹75 crore. The Board of Directors rescinded the approval granted on May 15, 2026, in a meeting held on August 12, 2026, citing internal considerations. No NCDs have been issued.
Read the summary - Medium impact
Mukka Proteins Re-appoints 6 Directors, Including MD & CEO, for 5-Year Terms
Mukka Proteins Limited's Board approved the re-appointment of six directors, including MD & CEO Mr. Kalandan Mohammed Haris. Three Independent Directors and three Whole-Time Directors will serve for five-year terms starting January 2027. These appointments are subject to shareholder approval at the upcoming 16th AGM.
Read the summary - High impact
Mukka Proteins Approves Q1 FY27 Results, Reappoints Directors, Invests in SESPL
Mukka Proteins approved Q1 FY27 results. Consolidated revenue was ₹489.65 crore, with PAT ₹18.63 crore. Standalone revenue was ₹405.86 crore, with PAT ₹19.41 crore. The company will hold its AGM on Sep 10, 2026. It will invest ₹64.92 lakh in Swachha Eco Solutions and reappointed key directors and management for five-year terms starting Jan 2027.
Read the summary - Medium impact
Mukka Proteins Approves Q1 FY27 Results, Reappoints Key Directors, and Invests in Waste Management
Mukka Proteins approved Q1 FY27 unaudited financial results. The company will hold its AGM on September 10, 2026. It cancelled the proposed ₹75 crore NCD issuance and will invest ₹64.925 lakh in Swachha Eco Solutions Private Limited, making it an associate. Key directors and management, including MD Kalandan Mohammed Haris, were re-appointed for five-year terms starting January 2027.
Read the summary - High impact
Mukka Proteins shareholders approve ₹47 Crore preferential issue of warrants
Mukka Proteins shareholders approved the issuance of up to 2 crore warrants convertible into equity shares. The total issue size is ₹47 crore at ₹23.50 per warrant. The resolution was passed via postal ballot with a majority of votes in favor.
Read the summary - Medium impact
Mukka Proteins Wins Customs Tribunal Case, ₹15.24 Crore Demand Set Aside
Mukka Proteins Limited has won a significant customs tribunal case. The Hon'ble CESTAT set aside a demand of ₹15,24,30,536, including interest and penalties, related to imported fish meal valuation. The order, dated June 24, 2026, was received on August 6, 2026. The company may also claim a refund of ₹75 lakh.
Read the summary - Medium impact
Mukka Proteins Shareholders Approve Preferential Issuance of Warrants
Mukka Proteins Limited shareholders approved the preferential issuance of warrants convertible into equity shares. The resolution passed with 99.96% of valid votes in favour. Remote e-voting concluded on July 12, 2026.
Read the summary - Low impact
Mukka Proteins Files SEBI Compliance Certificate for Q1 FY27
Mukka Proteins Limited submitted a certificate for the quarter ended June 30, 2026, as per SEBI regulations. The RTA confirmed no demat requests were processed as shares are not in physical form.
Read the summary - Low impact
Mukka Proteins: Corrigendum to Postal Ballot Notice Published in Newspapers
Mukka Proteins Limited published a corrigendum to its postal ballot notice dated June 12, 2026, on July 7, 2026. The notice was published in Business Standard and Vijaya Karnataka, confirming the dispatch of the corrigendum to shareholders.
Read the summary - Medium impact
Mukka Proteins Issues Corrigendum for Preferential Issue of Warrants
Mukka Proteins is issuing 2 Crore warrants at ₹23.50 each, raising ₹47 Crores. Funds will support working capital, business expansion, and general corporate needs. The issue price is based on SEBI regulations and a valuer's report. Shareholders can revise their votes by July 12, 2026.
Read the summary - Low impact
Mukka Proteins Promoters Confirm No Share Encumbrance for FY26
Mukka Proteins Limited promoters and promoter group confirm no encumbrance on shares for FY26 under SEBI Takeover Regulations. The disclosure lists promoter holdings.
Read the summary - Low impact
Mukka Proteins publishes newspaper advertisement for postal ballot notice.
Mukka Proteins Limited published a newspaper advertisement on June 13, 2026, regarding its postal ballot notice. E-voting is open from June 13 to July 12, 2026, for shareholders registered as of June 10, 2026. The vote concerns the issuance of warrants convertible into equity shares on a preferential basis.
Read the summary - Medium impact
Mukka Proteins plans ₹47 Crore preferential issue via warrants
Mukka Proteins Limited is proposing to issue 2 Crore Convertible Warrants at ₹23.50 each, aggregating ₹47 Crore. The warrants are convertible into equity shares within 18 months. The company has applied for in-principle approval from stock exchanges and will seek shareholder approval via postal ballot. E-voting period is June 13 to July 12, 2026.
Read the summary - Medium impact
Mukka Proteins to issue 2 crore warrants convertible to equity shares worth ₹47 crore on preferential basis
Mukka Proteins will issue up to 2 crore warrants convertible into equity shares on a preferential basis. The total issue size is ₹47 crore, with each warrant priced at ₹23.50. Conversion into shares is permitted within 18 months. E-voting for shareholder approval runs from June 13, 2026, to July 12, 2026.
Read the summary - Medium impact
Mukka Proteins to Acquire 51% Stake in Delta Marine Products for ₹11.10 Crore
Mukka Proteins will acquire a 51% stake in Delta Marine Products for up to ₹11.10 crore. The investment aims to expand the company's core business. Delta Marine Products had a turnover of ₹28.17 crore in FY25. The acquisition is expected to be completed by September 30, 2026.
Read the summary - Medium impact
Mukka Proteins to Acquire 51% Stake in Aqua Marine for up to ₹15 Crore
Mukka Proteins will acquire a 51% stake in Aqua Marine for up to ₹15 crore. The investment aims to expand core business and optimize operations. Aqua Marine, a manufacturer of fish meals and fish oil, had a turnover of ₹32.15 crore in FY25. The acquisition is expected to be completed by September 30, 2026.
Read the summary - High impact
Mukka Proteins Approves ₹47 Crore Preferential Issue & ₹26.1 Crore Investment in Marine Firms
Mukka Proteins will issue 2 crore warrants at ₹23.50 each, raising ₹47 crore. The company will also invest ₹11.1 crore in Delta Marine Products and ₹15 crore in Aqua Marine. These strategic investments aim to expand the company's core business. The Board approved these decisions on June 12, 2026.
Read the summary - High impact
Mukka Proteins Approves ₹47 Cr Preferential Warrants & ₹26.1 Cr Strategic Investments
Mukka Proteins approved issuing 2 crore warrants worth ₹47 crore to non-promoters at ₹23.50 each. The board also approved investments of ₹11.10 crore in Delta Marine Products and ₹15 crore in Aqua Marine. These strategic investments aim to expand the company's core business. Shareholder approval will be sought via postal ballot.
Read the summary - High impact
Mukka Proteins' Long-Term Ratings Downgraded to CARE BBB-; Negative by CARE Ratings
CARE Ratings downgraded Mukka Proteins' long-term bank facilities to CARE BBB-; Negative and its long-term/short-term facilities to CARE BBB-; Negative / CARE A3. The downgrade is due to an elongated working capital cycle and high inventory levels, impacting liquidity. Revenue grew 45% to ₹1,468 crore in FY26, but debt coverage indicators deteriorated.
Read the summary - Medium impact
Mukka Proteins Presents Q4 & FY26 Investor Presentation
Mukka Proteins Limited released its Q4 & FY26 Investor Presentation. For FY26, Total Income was ₹1,478.20 crore, and Profit was ₹57.10 crore. Revenue from operations reached ₹1,449.5 crore. The company is expanding into Sri Lanka and Oman, and secured a waste management contract. It projects revenues to exceed ₹3,000 crore by FY30.
Read the summary - High impact
Mukka Proteins FY26 Revenue Surges 44% to ₹1,449.5 Crore; PAT Up 18.7%
Mukka Proteins reported FY26 consolidated revenue of ₹1,449.5 crore, up 44% YoY. EBITDA rose 30.9% to ₹145.3 crore and PAT increased 18.7% to ₹57.1 crore. Q4 FY26 saw revenue at ₹380.6 crore with PAT up 52.6% YoY to ₹21.4 crore. The company is expanding in Oman and Sri Lanka and secured a waste management contract.
Read the summary - Low impact
Mukka Proteins Limited Announces Audited Financial Results for Q4FY26
Mukka Proteins Limited announced its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The Board of Directors approved these results on May 15, 2026. The information was published in newspapers on May 16, 2026.
Read the summary - Medium impact
Mukka Proteins to Incorporate Partnership Firm 'MPL FC HRC JV'
Mukka Proteins will incorporate 'MPL FC HRC JV' with a proposed capital of ₹5,00,000. The company will contribute ₹2,55,000 for a 51% stake in the partnership, focusing on animal waste treatment. Completion is expected by July 31, 2026.
Read the summary - Medium impact
Mukka Proteins to Incorporate Overseas Entity in Sri Lanka
Mukka Proteins will incorporate 'Lanka Bio Proteins Private Limited' in Sri Lanka. The company will invest up to ₹2.50 crore for a 49% stake. This aims to expand international operations and strengthen its marine products presence.
Read the summary - Medium impact
Mukka Proteins Approves Fund Raising Via NCDs Worth ₹75 Crore
Mukka Proteins Limited's Board approved raising funds via Non-Convertible Debentures (NCDs). The company will issue NCDs worth up to ₹25 crore through EBP and an additional ₹50 crore in one or more tranches. The meeting was held on May 15, 2026.
Read the summary - High impact
Mukka Proteins Approves ₹75 Crore Fundraising, Invests in JV and Overseas Entity
Mukka Proteins approved audited financial results for Q4FY26 and FY26. The company will raise up to ₹25 crore via NCDs through private placement and another ₹50 crore via NCDs. It will invest ₹2.55 lakh in MPL FC HRC JV and up to ₹2.50 crore in Lanka Bio Proteins Private Limited in Sri Lanka.
Read the summary - Low impact
Mukka Proteins enters ₹5 Crore loan agreement with subsidiary United Gulf Fishery Products LLC
Mukka Proteins Limited has entered into a loan agreement with its subsidiary, United Gulf Fishery Products LLC, for an amount up to ₹5 Crore. The unsecured loan carries an interest rate of 8% per annum and has a tenure of five years. The agreement was executed on April 21, 2026.
Read the summary - Low impact
Mukka Proteins Limited Files SEBI Regulation 74(5) Certificate for Q4 FY26
Mukka Proteins Limited filed a certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026. The Registrar confirmed no demat requests were processed as no shares are in physical mode. This is a routine compliance filing.
Read the summary - Medium impact
Mukka Proteins Completes Acquisition of Haris Marine Products, Making it a Wholly Owned Subsidiary
Mukka Proteins Limited has acquired 2,000 equity shares in Haris Marine Products Private Limited for ₹19,64,000, making it a wholly-owned subsidiary. The acquisition aims to expand the company's core business in fish meal and fish oil manufacturing and export. The transaction was completed on March 30, 2026.
Read the summary - Low impact
Mukka Proteins: Trading Window Closed from April 1, 2026 for FY26 Financial Results
Mukka Proteins Limited's trading window will be closed from April 1, 2026, until 48 hours after the declaration of financial results for the quarter and year ending March 31, 2026. This is in compliance with insider trading regulations.
Read the summary - Medium impact
Mukka Proteins Acquires Remaining 2% Stake in Haris Marine Products for ₹19.64 Lakhs
Mukka Proteins Limited acquired the remaining 2% stake in Haris Marine Products Private Limited for ₹19.64 Lakhs on March 25, 2026. This consolidates their ownership to 100%. The transaction involves related parties.
Read the summary - Low impact
Mukka Proteins Subsidiary Renamed to MPL HRC JATHIN ECOSOLUTIONS LLP
Mukka Proteins Limited's subsidiary, MPL HRC ECOSOLUTIONS LLP, has been renamed MPL HRC JATHIN ECOSOLUTIONS LLP. The change was approved by the Ministry of Corporate Affairs (MCA).
Read the summary - Low impact
Mukka Proteins to Participate in Investor Meetings Starting March 12, 2026
Mukka Proteins Limited will participate in investor group meetings starting March 12, 2026. The first event is a virtual one-on-one meeting with QRC Investment Advisors LLP. No unpublished price-sensitive information will be shared.
Read the summary - Low impact
Mukka Proteins to Participate in Investor Meetings on March 10, 2026
Mukka Proteins Limited will participate in investor group meetings on March 10, 2026. The company will hold virtual one-on-one meetings with ICICI Securities and Kotak MF. No unpublished price-sensitive information will be shared.
Read the summary - Low impact
Mukka Proteins to Participate in Investor Group Meetings from March 6
Mukka Proteins Limited will participate in investor group meetings starting March 6, 2026. The company will hold a virtual one-on-one meeting with the International Finance Corporation (IFC). No unpublished price-sensitive information will be shared. The latest investor presentation is available on the company website.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio - Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio - Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio - Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio